Carbon Dioxide → HCID 22876606, compound
Reaction equation
[C:1]([NH:8][CH2:9][C:10]([OH:12])=O)([O:3][C:4]([CH3:7])([CH3:6])[CH3:5])=[O:2].[C:13]([N:20]1C=CN=C1)([N:15]1C=CN=C1)=O.C(=O)=O.[F:28][C:29]([F:48])([F:47])[C:30]1[C:35]2[C:36](=[O:46])[N:37]3[CH2:45][CH2:44][C@H:38]3[C:39]3[N:40]([CH:41]=[N:42][CH:43]=3)[C:34]=2[CH:33]=[CH:32][CH:31]=1>CN(C)C=O>[C:1]([NH:8][CH2:9][C:10]1[O:12][N:20]=[C:13]([C:43]2[N:42]=[CH:41][N:40]3[C:34]4[CH:33]=[CH:32][CH:31]=[C:30]([C:29]([F:28])([F:47])[F:48])[C:35]=4[C:36](=[O:46])[N:37]4[CH2:45][CH2:44][C@H:38]4[C:39]=23)[N:15]=1)([O:3][C:4]([CH3:5])([CH3:6])[CH3:7])=[O:2]Participants
Procedure
4.2 g (24 mmol) of BOC-glycine were dissolved in 40 ml of N,N-dimethylformamide and treated portionwise with 4.05 g (25 mmol) of 1,1'-carbonyldiimidazole. After completion of the CO2 evolution the solution was stirred at 50° for 20 min. Then, 7.7 g (22 mmol) of (S)-8-trifluoromethyl-12,12a-dihydro-9-oxo-9H,11H-azeto[2,1-c]imidazo[1,5-a][1,4]benzodiazepine were added and the mixture was stirred at 90° overnight. The reaction mixture was concentrated and the residue was dissolved in methylene chloride. By washing, drying and evaporating the organic phase there were obtained 7.82 g (72%) of (S)-1-[5-(N-BOC-aminomethyl)-1,2,4-oxadiazol-3-yl]-8-trifluoromethyl-12,12a-dihydro-9H,11H-azeto[2,1-c]imidazo[1,5-a][1,4]benzodiazepin-9-one, which was used in the next step without further purification.
Workup
- concentrationThe reaction mixture was concentrated
- dissolutionthe residue was dissolved in methylene chloride
- washBy washing
- customdrying
- customevaporating the organic phase there
Sources & evidence
- ORD record
- ord-8b0529345be8437bbca9d78e1e173085
- Source dataset
- uspto-grants-1997_09
- Patent number
- US05665718
Reaction notes
Loading…